Literature DB >> 2332472

Prevalence of seroreactors to the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae in swine herds.

J Devenish1, S Rosendal, J T Bossé, B N Wilkie, R Johnson.   

Abstract

A rabbit homologous polyclonal antiserum to the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae serotype 1 strain CM-5 was specifically produced and used in an antigen capture enzyme-linked immunosorbent assay (ELISA) to detect swine serum antibodies to this potentially important virulence factor. Sera from pigs experimentally infected with the most common disease-producing serotypes (serotypes 1, 2, 5, and 7) of A. pleuropneumoniae produced positive results in this ELISA. Of 144 serum samples collected from 10 herds free of pleuropneumonia and 155 serum samples from 11 herds with a history of the disease, 68 (47%) and 148 (95%), respectively, were found positive by the ELISA. In addition, pigs naturally infected with Actinobacillus suis produced antibodies which seroreacted in this ELISA. The results indicated that a high proportion of swine have antibodies seroreactive with the 104-kilodalton hemolysin produced by A. pleuropneumoniae.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2332472      PMCID: PMC267796          DOI: 10.1128/jcm.28.4.789-791.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Analysis of major antigens of Haemophilus (Actinobacillus) pleuropneumoniae and related organisms.

Authors:  J I MacInnes; S Rosendal
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

2.  Morphological and biochemical comparison of virulent and avirulent isolates of Haemophilus pleuropneumoniae serotype 5.

Authors:  A E Jensen; T A Bertram
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

3.  Enzyme immunoassay: observations on aspects of quality control.

Authors:  P Wright
Journal:  Vet Immunol Immunopathol       Date:  1987-12       Impact factor: 2.046

4.  Immunoserological comparison of 104-kilodalton proteins associated with hemolysis and cytolysis in Actinobacillus pleuropneumoniae, Actinobacillus suis, Pasteurella haemolytica, and Escherichia coli.

Authors:  J Devenish; S Rosendal; R Johnson; S Hubler
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

5.  Acute inflammatory effects of intratracheally instilled Escherichia coli endotoxin and sonicated suspension of Haemophilus pleuropneumoniae in swine.

Authors:  A D Liggett; L R Harrison; R L Farrell
Journal:  Can J Vet Res       Date:  1986-10       Impact factor: 1.310

6.  Isolation and biological characterization of two lipopolysaccharides and a capsular-enriched polysaccharide preparation from Haemophilus pleuropneumoniae.

Authors:  B W Fenwick; B I Osburn; H J Olander
Journal:  Am J Vet Res       Date:  1986-07       Impact factor: 1.156

7.  Determination of antigenic specificity and relationship among Haemophilus pleuropneumoniae serotypes by an indirect hemagglutination test.

Authors:  K R Mittal; R Higgins; S Lariviere
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

8.  Evaluation of heat-sensitive, neutrophil-toxic, and hemolytic activity of Haemophilus (Actinobacillus) pleuropneumoniae.

Authors:  S Rosendal; J Devenish; J I MacInnes; J H Lumsden; S Watson; H Xun
Journal:  Am J Vet Res       Date:  1988-07       Impact factor: 1.156

9.  Evaluation of different antigens in the complement-fixation test for diagnosis of Haemophilus pleuropneumoniae (parahaemolyticus) infections in swine.

Authors:  A Gunnarsson
Journal:  Am J Vet Res       Date:  1979-11       Impact factor: 1.156

10.  Haemophilus pleuropneumoniae serotypes--cross protection experiments.

Authors:  R Nielsen
Journal:  Nord Vet Med       Date:  1984 Jul-Aug
View more
  9 in total

1.  Molecular characterization of an RTX toxin determinant from Actinobacillus suis.

Authors:  L L Burrows; R Y Lo
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants.

Authors:  W Byrd; S Kadis
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Humoral antibody response and protective immunity in swine following immunization with the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae.

Authors:  J Devenish; S Rosendal; J T Bossé
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  Identification of a second hemolysin (HlyII) in Actinobacillus pleuropneumoniae serotype 1 and expression of the gene in Escherichia coli.

Authors:  J Frey; H van den Bosch; R Segers; J Nicolet
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

5.  Nucleotide sequence of the hemolysin I gene from Actinobacillus pleuropneumoniae.

Authors:  J Frey; R Meier; D Gygi; J Nicolet
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

6.  Identification of hemolytic and cytotoxic proteins of Actinobacillus pleuropneumoniae by use of monoclonal antibodies.

Authors:  E M Kamp; J K Popma; J Anakotta; M A Smits
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

7.  Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype 1.

Authors:  J T Bossé; R P Johnson; M Nemec; S Rosendal
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

8.  Prevalence of Actinobacillus pleuropneumoniae, Actinobacillus suis, Haemophilus parasuis, Pasteurella multocida, and Streptococcus suis in representative Ontario swine herds.

Authors:  Janet I MacInnes; Marcelo Gottschalk; Abdul G Lone; Devon S Metcalf; Shivani Ojha; Thomas Rosendal; Sheila B Watson; Robert M Friendship
Journal:  Can J Vet Res       Date:  2008-04       Impact factor: 1.310

9.  Production of Apx toxins by field strains of Actinobacillus pleuropneumoniae and Actinobacillus suis.

Authors:  E M Kamp; T M Vermeulen; M A Smits; J Haagsma
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.